Pluri Inc. Total Assets
Pluri Inc. total assets. Based on the latest financial reports, Pluri Inc. (PLUR) holds total assets worth $26.06 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Pluri Inc. for the company's overall valuation and market capitalisation.
Total Assets of Pluri Inc. (2002–2025)
Total assets of Pluri Inc. from 2002 to 2025. This chart illustrates how Pluri Inc.'s total assets have evolved over time, based on quarterly financial data. See Pluri Inc. share price for real-time trading data and today's change.
Pluri Inc. - Asset Composition Analysis
Pluri Inc. Total Assets Breakdown (June 2025)
Pluri Inc. total assets breakdown as of June 2025. Pluri Inc.'s total assets of $26.06 Million consist of 57.1% current assets and 42.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.2% |
| Accounts Receivable | $722.00K | 1.9% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.79 Million | 7.2% |
| Goodwill | $3.14 Million | 8.1% |
Asset Composition Trend (2002–2025)
This chart illustrates how Pluri Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Pluri Inc. to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pluri Inc.'s current assets represent 57.1% of total assets in 2025, an increase from 5.8% in 2002.
- Cash Position: Cash and equivalents constituted 15.2% of total assets in 2025, up from 5.8% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 8.1% of total assets.
Pluri Inc. Competitors by Total Assets
Key competitors of Pluri Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Pluri Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.33 | 4.81 | 5.85 |
| Quick Ratio | 0.33 | 4.81 | 5.85 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-21.54 Million | $21.75 Million | $55.85 Million |
Pluri Inc. - Advanced Valuation Insights
This section examines the relationship between Pluri Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 306.56 |
| Latest Market Cap to Assets Ratio | 0.39 |
| Asset Growth Rate (YoY) | -2.1% |
| Total Assets | $38.68 Million |
| Market Capitalization | $15.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pluri Inc.'s assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Pluri Inc.'s assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Pluri Inc. (2002–2025)
The table below shows the annual total assets of Pluri Inc. from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $38.68 Million | -2.14% |
| 2024-06-30 | $39.53 Million | -22.19% |
| 2023-06-30 | $50.80 Million | -25.37% |
| 2022-06-30 | $68.06 Million | -27.23% |
| 2021-06-30 | $93.54 Million | +42.74% |
| 2020-06-30 | $65.53 Million | +109.30% |
| 2019-06-30 | $31.31 Million | -19.64% |
| 2018-06-30 | $38.96 Million | +3.80% |
| 2017-06-30 | $37.53 Million | -18.30% |
| 2016-06-30 | $45.94 Million | -32.59% |
| 2015-06-30 | $68.16 Million | -7.93% |
| 2014-06-30 | $74.02 Million | +8.35% |
| 2013-06-30 | $68.32 Million | +44.07% |
| 2012-06-30 | $47.42 Million | +3.05% |
| 2011-06-30 | $46.02 Million | +718.50% |
| 2010-06-30 | $5.62 Million | +25.97% |
| 2009-06-30 | $4.46 Million | +24.53% |
| 2008-06-30 | $3.58 Million | -46.72% |
| 2007-06-30 | $6.73 Million | +96.42% |
| 2006-06-30 | $3.42 Million | +30.71% |
| 2005-06-30 | $2.62 Million | +90.24% |
| 2004-06-30 | $1.38 Million | +38.47% |
| 2003-06-30 | $994.59K | +5914.72% |
| 2002-06-30 | $16.54K | -- |
About Pluri Inc.
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, … Read more